All News

Genzyme has to provide FDA with more data on Synvisc-One before the pain-relieving treatment for osteoarthritis can be approved.

FDA adds new warnings to erythropoiesis-stimulating agents' labels.

New indication for rosuvastatin (Crestor) approved.

New delivery device approved for somatropin (Saizen).

Pharmacy students should be given good training when they are doing their internships and externships, not used as a replacement for vacationing staff.

U.S. Career Institute announces pharmacy technician course.

Nevada pharmacists demand a vote on Fair Medicaid Drug Payment Act, while House judiciary committee unanimously approves PBM legislation.

A new study finds that Retail clinic's revenues could reach nearly $4.5 billion by 2011.

DEA kicks off exhibit about drug diversion and abuse.

Rite Aid responds to union protest

Medicare Part D prescription drug plans owe more than $4 billion to CMS

More than 70,000 medication therapy management services have been offered through the Community Care Rx (CCRx) program, according to an announcement from Mirixa

PDX-NHIN and Health Market Science will jointly market the HMS database with 1.8 million prescriber records including NPI numbers

Michigan Pharmacists Association announces plans for a medication therapy management company to expand MTM opportunities

Giant Eagle expands $4 generic prescription drug program

A new report by the Office of Inspector General found that some generic manufacturers keep raising their drug prices above the inflationary rate, making them deserve to pay more Medicaid rebates

APHA adopts policy against feminine hygiene douching practices

AstraZeneca launches Nexium savings program for Purple Plus members

NACDS and NCPA sue to block implementation of the average manufacturer price rule set to take effect in January.

A new survey of four health disciplines reveals that they think Medicare Part D has hurt the care provided in long-term care facilities.

Seniors are satisfied with Medicare Part D drug benefit.

Reinforcements on way to fight infectious diseases.

Union protest targets Rite Aid.

In a new paper, the Biotechnology Industry Organization reveals it has reservations about the use of comparative effectiveness in reviewing products.

Humana announced that, starting in January, members in its Medicare drug plans don't have to pay a co-pay for Tier 1 generics.

CVS pharmacists help diabetes patients.

Bayer suspends worldwide marketing of antifibrolytic Trasylol.

FDA requests recall of True Man Sexual Energy, Energy Max dietary supplements.